BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1427 related articles for article (PubMed ID: 11818483)

  • 21. [Physiological and pharmacological function of PPARs].
    Takahashi N; Kawada T
    Nihon Yakurigaku Zasshi; 2001 May; 117(5):319-27. PubMed ID: 11411341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
    Guan Y; Breyer MD
    Kidney Int; 2001 Jul; 60(1):14-30. PubMed ID: 11422732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis].
    Fruchart JC; Staels B; Duriez P
    Bull Acad Natl Med; 2001; 185(1):63-74; discussion 74-5. PubMed ID: 11474570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
    Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
    Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptors and the cardiovascular system.
    Chen YE; Fu M; Zhang J; Zhu X; Lin Y; Akinbami MA; Song Q
    Vitam Horm; 2003; 66():157-88. PubMed ID: 12852255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
    Uauy R; Martínez JI; Rojas CV
    Rev Med Chil; 2000 Apr; 128(4):437-46. PubMed ID: 10962863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptors: from genes to physiology.
    Kliewer SA; Xu HE; Lambert MH; Willson TM
    Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
    Moller DE; Berger JP
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview on biological mechanisms of PPARs.
    Kota BP; Huang TH; Roufogalis BD
    Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J; Wójcicka G; Jamroz A
    Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle.
    Gilde AJ; Van Bilsen M
    Acta Physiol Scand; 2003 Aug; 178(4):425-34. PubMed ID: 12864748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.
    Ferré P
    Diabetes; 2004 Feb; 53 Suppl 1():S43-50. PubMed ID: 14749265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.
    Dana SL; Hoener PA; Bilakovics JM; Crombie DL; Ogilvie KM; Kauffman RF; Mukherjee R; Paterniti JR
    Metabolism; 2001 Aug; 50(8):963-71. PubMed ID: 11474486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
    Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptors (PPARs) in health and disease.
    Ehrmann J; Vavrusová N; Collan Y; Kolár Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2002 Dec; 146(2):11-4. PubMed ID: 12572888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.